Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAART-treated”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00427297
What this trial is testing

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Who this might be right for
HIV Infections
University of Washington 34
Early research (Phase 1)Study completedNCT00024986
What this trial is testing

Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT00491556
What this trial is testing

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 102
Early research (Phase 1)Study completedNCT00080431
What this trial is testing

Daclizumab to Treat HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Study completedNCT00352053
What this trial is testing

Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy

Who this might be right for
HIV Infections
Gilead Sciences 87
Not applicableStudy completedNCT02712489
What this trial is testing

A Roll-over Observational Study for the Extended Follow-up of the Volunteers of the ISS T-003 Trial

Who this might be right for
HIV Infections
Barbara Ensoli, MD, PhD 179
Large-scale testing (Phase 3)Study completedNCT01766076
What this trial is testing

Atorvastatin for HAART Suboptimal Responders

Who this might be right for
Acquired Immune Deficiency Syndrome Virus
Makerere University 30
Early research (Phase 1)Ended earlyNCT00195312
What this trial is testing

Study Evaluating Vaccine in Adults With HIV

Who this might be right for
HIV Infections
Wyeth is now a wholly owned subsidiary of Pfizer 91
Testing effectiveness (Phase 2)Study completedNCT00299338
What this trial is testing

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

Who this might be right for
HIV Infections
Samaritan Pharmaceuticals, Inc 24
Post-approval studies (Phase 4)Ended earlyNCT00598910
What this trial is testing

Effect of Omacor on Triglycerides in HIV Infected Subjects

Who this might be right for
Hyper-Triglyceridemia
Solvay Pharmaceuticals 51
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00121979
What this trial is testing

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Who this might be right for
HIV Infections
Pharmasset 60
Not applicableStudy completedNCT00683579
What this trial is testing

Neurocognitive Assessment in Youth Initiating HAART

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 220
Testing effectiveness (Phase 2)Study completedNCT01402466
What this trial is testing

Urban Health Study II

Who this might be right for
HIV
RTI International 49
Post-approval studies (Phase 4)Ended earlyNCT00234962
What this trial is testing

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

Who this might be right for
HIV Infection
Abbott 200
Post-approval studies (Phase 4)Study completedNCT00885482
What this trial is testing

Atazanavir and Lamivudine for Treatment Simplification

Who this might be right for
HIV Infections
Catholic University of the Sacred Heart 40
Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Testing effectiveness (Phase 2)Ended earlyNCT00035581
What this trial is testing

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Who this might be right for
HIV SeropositivityHIV Infection
AIM ImmunoTech Inc. 16
Not applicableUnknownNCT00716040
What this trial is testing

Social-Psychological Intervention to Improve Adherence to HAART

Who this might be right for
AIDSHIV Infections
University of Sao Paulo 121
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation